Search
for
Sort by
Research 121–150 of 351
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Current Insight of Peptide-Based Hydrogels for Chronic Wound Healing Applications: A Concise Review
- Identification of Candidate Genes for Min Pig Villi Hair Traits by Genome-Wide Association of Copy Number Variation
- Metabolic syndrome — a new definition and management guidelines
- Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
- Polyzystisches Ovar-Syndrom (PCOS)
- The clinical spectrum of parathyroid disease
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Neuroendokrine paraneoplastische Syndrome
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective